Screener
BioRestorative Therapies BRTX Q3 2025 earnings
Reported November 12, 2025 · After market close
Revenue$11.8KMiss by $448.2K
EPS-$0.33Beat by $0.03
Revenue estimate$460.0K
EPS estimate-$0.36
Next report
Sep 22, 2026 (In 4 days)Revenue estimate$600.0K
EPS estimate-$2.00
Versus estimates
Revenue
Diluted EPS
FAQ
- When did BioRestorative Therapies report Q3 2025 earnings?
- BioRestorative Therapies (BRTX) reported Q3 2025 earnings on November 12, 2025 after market close.
- What were BioRestorative Therapies's Q3 2025 revenue and EPS?
- BioRestorative Therapies reported revenue of $11.8K and eps of $-0.33 for Q3 2025.
- Did BioRestorative Therapies beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $460.0K by $448.2K. EPS beat the consensus estimate of $-0.36 by $0.03.
- How did BioRestorative Therapies's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 94.9% from $233.6K a year earlier and eps declined 153.8% from $-0.13.
- Where can I find BioRestorative Therapies's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001021771-25-000148) and the 10-Q periodic report (0001493152-25-021993) directly on SEC EDGAR. The filing index links above go to sec.gov.
